Quantitative assessment of aortic atherosclerosis in APOE*3 leiden transgenic mice and its relationship to serum cholesterol exposure

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 8, 1996, Pages 926-933

  Groot, Pieter H E ^a   Van Vlijmen, Bart J M ^b   Benson, G Martin ^a   Hofker, Marten H ^b   Schiffelers, Raymond ^a   Vidgeon Hart, Martin ^a   Havekes, Louis M ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b TNO   (Netherlands)

Author keywords

animal model; apolipoprotein E; diet; familial dyslipoproteinemia; hyperlipidemia

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; DYSLIPOPROTEINEMIA; FEEDING; FEMALE; HYPERLIPIDEMIA; HYPOLIPEMIA; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0029836439     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.8.926     Document Type: Article

References (25)

1. Havel RJ, Chow YS, Windler E, Kotite L, Guo LSS. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathophysiology of familial dysbetalipoproteinemia. Proc Natl Acad Sci U S A. 1980;77:4349-4353.
2. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240:622-630.
3. Mahley RW, Innerarity TL, Rail SC, Weisgraber KH, Taylor JM. Apolipoprotein E: genetic variants provide insight into its structure and function. Curr Opin Lipidol. 1990;1:87-95.
4. Havekes L, de Wit E, Gevers Leuven J, Klasen E, Utermann G, Weber W, Beisiegel U. Apolipoprotein E3 Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet. 1986;73:157-163.
5. van den Maagdenberg AM, de Knijff P, Stalenhoef AFM, Gevers Leuven J, Havekes LM, Frants RR. Apolipoprotein E*3 Leiden allele results from a partial gene duplication in exon 4. Biochem Biophys Res Commun. 1989;165:851-857.
6. Wardell MR, Weisgraber KH, Havekes LM, Rail SC. Apolipoprotein E3 Leiden contains a seven-amino acid insertion that is a tandem repeat of residues 121 to 121. J Biol Chem. 1989;264:21205-21210.
7. Fazio SY, Horie KH, Weisgraber KH, Havekes LM, Rail SC. Preferential association of apolipoprotein E Leiden with very low density lipoproteins of human plasma. J Lipid Res. 1993;34:447-453.
8. van den Maagdenberg AMJM, Hofker MH, Krimpenfort PJA, de Bruijn I, van Vlijmen B, van der Boom H, Havekes LM, Frants RR. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem. 1993;268:10540-10545.
9. van Vlijmen BJM, van den Maagdenberg AMJM, Gijbels MJJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest. 1994;93:1403-1410.
10. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res. 1990;31:859-869.
11. Nishina PM, Lowe S, Verstuyft J, Naggert JK, Kuypers FA, Paigen B. Effects of dietary fats from animal and plant sources on diet-induced fatty streak lesions in C57B1/6J mice. J Lipid Res. 1993;34:1413-1422.
12. Paigen BA, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerosis in mice. Atherosclerosis. 1987;68:231-240.
13. Qiao J-H, Xie P-Z, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice. Arterioscler Thromb. 1994;14:1480-1497.
14. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice, created by homologous recombination in ES cells. Cell. 1992;71:343-353.
15. Zhand S, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
16. van Ree JH, van den Broek WJAA, Dahlmans VEH, Groot PHE, Vidgeon-Hart M, Frants RR, Wieringa E, Havekes LM, Hofker MH. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice. Atherosclerosis. 1994;111:25-37.
17. Nakashima Y, Plump AS, Raines EWR, Breslow JL, Ross R. Apo E-deficient mice develop lesions in all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133-140.
18. Basu SK, Goldstein JL, Brown MS. Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. Science. 1983;219:871-873.
19. Rosenfeld ME, Butler S, Ord VA, Lipton BA, Dyer CA, Curtiss LK, Palinski W, Witztum JL. Abundant expression of apolipoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb. 1993;13:1382-1389.
20. 2+ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms, I: characterization of cellular lipid metabolism. Arteriosclerosis. 1988;8:46-56.
21. Kruth HS, Skarlatos SI, Gaynor PM, Gamble W. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J Biol Chem. 1994;269:24511-24518.
22. Linton RF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 1995;267:1034-1037.
23. Shimano H, Ohsuga JO, Shimada M, Namba Y, Gotoda T, Harada K, Katsuki M, Yazaki Y, Yamada N. Inhibition of diet-induced atheroma formation in transgenic mice expressing apolipoprotein E in the arterial wall. J Clin Invest. 1995;95:469-476.
24. Fazio S, Sanan DA, Lee Y-L, Ji Z-S, Mahley RW, Rail SC. Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E (Arg 112, Cys 142). Arterioscler Thromb. 1994;14:1873-1879.
25. Shiomi M, Ito T, Shiraishi M, Watanabe Y. Inherilability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis. 1992;96:43-52.